Author:
Voznyuk I. A.,Pivovarova L. P.,Gogoleva E. A.,Osipova I. V.,Ariskina O. B.,Morozova E. M.,Chernyavsky I. V.,Markelova E. V.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. I. A. Voznyuk, S. N. Yanishevskii, P. V. Chechulov, et al., Ischemic Stroke: Clinical Guidelines for Primary and Secondary Prevention: Guidelines for Physicians, Dzhanelidze St. Petersburg Research Institute of Emergency Care, Stiks, St. Petersburg (2018).
2. M. A. Isgrò, P. Bottoni, and R. Scatena, “Neuron-specific enolase as a biomarker: Biochemical and clinical aspects,” Adv. Exp. Med. Biol., 867, 125–143 (2015), https://doi.org/1007/978-94-017-7215-0_9.
3. X. Hu, T. M. De Silva, et al., “Cerebral vascular disease and neurovascular injury in ischemic stroke,” Circ. Res., 120, No. 3, 449–471 (2017), https://doi.org/10.1161/CIRCRESAHA.116.308427.
4. E. G. Perdiguero and F. Geissmann, “The development and maintenance of resident macrophages,” Nat. Immunol., 17, No. 1, 2–8 (2016), https://doi.org/10.1038/ni.3341.
5. R. Brouns, B. De Vil, P. Cras, et al., “Neurobiochemical markers of brain damage in cerebrospinal fluid of ischemic stroke patients,” Clin. Chem., 56, No. 3, 451–458 (2010), https://doi.org/10.1373/clinchem.2009.134122.